You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Company Profile

Taisho Pharmaceutical Co Ltd in Consumer Health

Sep 2011

Price: US$525

About this Report

About this Report

Euromonitor International's report on Taisho Pharmaceutical Co Ltd delivers a detailed strategic analysis of the company's business, examining its performance in the Vitamins and Dietary Supplements market and the global economy.

Company and market share data provide a detailed look at the financial position of Taisho Pharmaceutical Co Ltd, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Taisho Pharmaceutical Co Ltd This report examines:

  • Company share by region and sector
  • Brand portfolio
  • New product developments
  • Marketing and distribution strategies

A detailed SWOT analysis of Taisho Pharmaceutical Co Ltd provides strategic intelligence on:

  • Strengths and weaknesses
  • Category and country opportunities for growth
  • Challenges and threats from current competition and future prospects
  • Global and regional market positions

Research You Can Trust

Euromonitor International's company profile reports are written by our Vitamins and Dietary Supplements research team, a dedicated group of analysts that knows the industry inside and out.

Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.

Delivery:
Reports are delivered in pdf format and can be downloaded from your online account (called My Pages) immediately after purchase.

Table of Contents

Table of Contents

Introduction

Scope

  • Introduction

Strategic Evaluation

Taisho: Japanese Focus

  • Strategic Evaluation

Financial analysis: Fiscal 2010

  • Strategic Evaluation

Taisho 2011 forecasts

  • Strategic Evaluation

SWOT: Taisho Pharmaceutical Co Ltd

  • Strategic Evaluation

Strategic objectives and challenges

  • Strategic Evaluation

Competitive Positioning

Reliance on Japan holds back Taisho

  • Competitive Positioning

Japanese fortunes influence Taisho’s performance

  • Competitive Positioning

Johnson & Johnson leads pack despite recalls

  • Competitive Positioning

Market Assessment

Taisho: strong presence in tonics and bottled nutritive drinks

  • Market Assessment

Asia Pacific still offers strongest opportunities for Taisho

  • Market Assessment

Geographic and Category Opportunities

Leverage Hoe acquisition to bring Taisho brands to Malaysia

  • Geographic and Category Opportunities

Indonesia: Cross-border opportunities in consumer health

  • Geographic and Category Opportunities

Lipovitan vulnerable to declines in Japanese market

  • Geographic and Category Opportunities

Develop Lipovitan beauty tonic and bottled nutritive drink

  • Geographic and Category Opportunities

Pan-Asia Pacific expansion should be Taisho’s priority

  • Geographic and Category Opportunities

Consider expansion into medicated confectionery and generics

  • Geographic and Category Opportunities

Consider expansion in analgesics through acquisition

  • Geographic and Category Opportunities

Poor outlook in Japan analgesics

  • Geographic and Category Opportunities

Hoe: A new armoury of tools for Taisho in medicated skin care

  • Geographic and Category Opportunities

Taisho well positioned in hair loss treatments

  • Geographic and Category Opportunities

Opportunities in medicated skin care

  • Geographic and Category Opportunities

Brand Strategy

International expansion for Lipovitan crucial

  • Brand Strategy

Pabron: Potential for growth

  • Brand Strategy

Operations

Distribution strategy and manufacturing facilities

  • Operations

Recommendations

International expansion should remain the priority

  • Recommendations

Samples

Please update/install flash.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!